pharmatodate.hidocdr.com Open in urlscan Pro
54.227.82.91  Public Scan

URL: https://pharmatodate.hidocdr.com/Rf0Lc1Pm6Wi0
Submission: On December 26 via manual from IN — Scanned from US

Form analysis 0 forms found in the DOM

Text Content

PHARMA TO DATE

Pharma Marketing


BRIDGING GAPS IN INVASIVE FUNGAL INFECTION MANAGEMENT: INSIGHTS FROM INDIAN
HEALTHCARE PROFESSIONALS

Ashi Gupta | 10 Dec, 2024

Invasive fungal infections (IFIs) are a critical health concern in India, often
presenting significant challenges in diagnosis and management. These infections
require timely and accurate treatment, but clinicians across various specialties
face barriers such as delays in therapy, limited access to advanced diagnostics,
and diverse patient factors. Understanding these issues was crucial to improving
outcomes for patients affected by IFIs.

Objective

The objective was to identify the specific challenges healthcare professionals
face in diagnosing and managing IFIs and gather actionable insights to enhance
clinical practices. A comprehensive survey was designed to target clinicians
across specialties like hematology, infectious diseases, critical care,
microbiology, oncology, and transplant surgery. The aim was to analyze
diagnostic practices, treatment preferences, and barriers to effective
management.

Strategy

To achieve this, a survey was conducted between July and August 2024 using a
digital outreach strategy. The initiative involved:

 1. Targeting 16,490 healthcare professionals through medical apps, email
    campaigns, and SMS.
 2. Designing two surveys (A and B) with a total of 20 questions, ensuring the
    same respondents completed both parts for comprehensive data collection.
 3. Engaging clinicians across private and government institutions to ensure
    diverse input.
 4. Analyzing participation by specialty, location, and experience to understand
    the breadth of the challenges.

The survey received robust engagement, with over 71,000 impressions, nearly
6,000 interactions, and an 8% click-through rate. Responses were collected from
intensivists, microbiologists, transplant physicians, and others, with the
highest participation from Maharashtra, followed by Delhi and Haryana.

Result

The survey successfully identified key challenges in IFI management, including
delays in antifungal therapy, varying diagnostic methods, and limited clinician
familiarity with newer treatments. Most responses came from private
institutions, highlighting their role in tackling complex conditions.

 * Key Insights: Intensivists provided the most responses, and younger
   professionals with less than 10 years of experience formed the majority of
   participants.
 * Impact: The findings underscore the need for targeted educational programs,
   better access to diagnostic tools, and enhanced collaboration across
   specialties.

The survey provided actionable data that can inform future initiatives, driving
improvements in IFI diagnosis and treatment. By fostering continued education
and leveraging digital platforms, clinicians can address existing gaps,
ultimately enhancing patient care and outcomes.

Conclusion

In conclusion, this initiative has not only illuminated the existing struggles
but also paved the way for transformative changes in the diagnosis and
management of invasive fungal infections. The collaborative spirit of the
healthcare community and the integration of innovative solutions are poised to
redefine patient care in this crucial area.


YOU MAY BE INTERESTED IN

--------------------------------------------------------------------------------


ELI LILLY APPOINTS LUCAS MONTARCE AS NEW CFO AMIDST ONGOING GROWTH

Rashmi P | 12 Sep, 2024


SHIFT IN DIETARY SUPPLEMENT MARKET REFLECTS EVOLVING CONSUMER PREFERENCES
POST-COVID-19

Rashmi | 29 Aug, 2024


CASE STUDY: INFLUENCER'S IMAGE - CRAFTING A STRONG CAREER AND PERSONAL BRAND BY
VASUDHA RAI

Rashmi P R | 25 Sep, 2024

--------------------------------------------------------------------------------




Fastest Growing Medical Platform for Doctors

Address:
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY,
82801

Email: info@hidoc.co